Extraction methods play a critical role in chemical profile and biological activities of black cohosh

Natural Product Communications

Volumn 3, Issue 9, 2008, Pages 1519-1532

  Jiang, Bei ^a,b   Reynertson, Kurt A ^b   Keller, Amy C ^b   Einbond, Linda S ^a   Bemis, Debra L ^a   Weinstein, I Bernard ^a   Kronenberg, Fredi ^a   Kennelly, Edward J ^b  

^a Columbia University ^*  (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Actaea racemosa; Black cohosh; Cimicifuga racemosa; Extraction methods; HPLC PDA; LC MS; Phytochemical analysis

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT; GLYCOSIDE; POLYPHENOL DERIVATIVE; SOLVENT; TRITERPENE DERIVATIVE; WATER;

ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL COMPOSITION; CIMICIFUGA RACEMOSA; CONTROLLED STUDY; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TEMPERATURE;

CIMICIFUGA DAHURICA; CIMICIFUGA RACEMOSA;

EID: 77954113446     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0800300925     Document Type: Article

References (54)

1. Foster S. (1999) Black cohosh: Cimicifuga racemosa. A literature review. HerbalGram, 45, 35-49;
2. Bilia AR, Eterno F, Vincieri FF (2007) Black cohosh and climacteric symptoms: growing knowledge about the efficacy and safety. Natural Product Communications, 2, 1043-1062.
3. Blumenthal M, Cavaliere C, Rea P. (2008) Herbal supplement sales in United States show growth in all channels. HerbalGram, 78, 60-63.
4. Gizicky HV. (1944) Arzneipflanzen in ihren Beziehungen zum weiblichen Genitalsystem. Versuche an weissen ratten und mausen mit Cimicifuga racemosa. Zeitschrift für die Gesamte Experimentelle Medizin, 113, 635-644.
5. Foldes J. (1959) The actions of an extract of Cimicifuga racemosa. Ärztliche Forschung, 13, 623-624.
6. Eagon CL, Elm MS, Teepe AG, Eagon PK. (1997) Medicinal botanicals: estrogenicity in rat uterus and liver. Proceeding of the American Association for Cancer Research, 38, 293.
7. Eagon PK, Tress NB, Ayer HA, Wiese JM, Henderson T, Elm MS, Eagon CL. (1999) Medicinal botanicals with hormonal activity. Proceeding of the American Association for Cancer Research, 40, 161-162.
8. Borrelli F, Izzo AA, Ernst E. (2003) Pharmacological effects of Cimicifuga racemosa. Life Sciences, 73, 1215-1229.
9. Liu Z, Yang Z, Zhu M, Huo J. (2001) Estrogenicity of black cohosh (Cimicifuga racemosa) and its effect on estrogen receptor level in human breast cancer MCF-7 cells. Wei Sheng Yan Jiu, 30, 77-80.
10. Jarry H, Harnischfeger G. (1985) Studies on the endocrine efficacy of the constituents of Cimicifuga racemosa: 1. Influence on the serum concentration of pituitary hormones in ovariectomized rats. Planta Medica, 51, 46-49.
11. Jarry H, Harnischfeger G, Düker EM. (1985) Studies on the endocrine efficacy of the constituents of Cimicifuga racemosa: 2. In vitro binding of constituents to estrogen receptors. Planta Medica, 51, 316-319.
12. Duker E-M, Kopanski L, Jarry H, Wuttke W. (1991) Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Medica, 57, 420-424.
13. Nisslein T, Freudenstein J. (2000) Effects of black cohosh on urinary bone markers and femoral density in an ovx-rat model. Osteoporosis International Abstract, 504.
14. Lohning A, Verspohl EJ, Winterhoff H. (1999) Pharmacological studies on the dopaminergic activity of Cimicifuga racemosa. 23rd International LOF-Symposium on phyto-oestrogens, University of Gent, Belgium,
15. Low Dog T, Powell KL, Weisman SM. (2003) Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause, 10, 299-313.
16. Mahady GB, Fabricant D, Chadwick LR, Dietz B. (2002) Black cohosh: An alternative therapy for menopause? Nutrition in Clinical Care, 5, 283-289.
17. Zierau O, Bodinet C, Kolba S, Wulf M, Vollmer G. (2002) Antiestrogenic activities of Cimicifuga racemosa extracts. Journal of Steroid Biochemistry & Molecular Biology, 80, 125-130.
18. Seidlova-Wuttke D, Hesse O, Jarry H, Christoffel V, Spengler B, Becker T, Wuttke W. (2003) Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. European Journal of Endocrinology, 149, 351-362.
19. Seidlova-Wuttke D, Jarry H, Becker T, Christoffel V, Wuttke W. (2003) Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus. Maturitas, 44 Suppl 1, 39-50.
20. Jarry H, Metten M, Spengler B, Christoffel V, Wuttke W. (2003) In vitro effects of the Cimicifuga racemosa extract BNO 1055. Maturitas, 44 Suppl 1, S31-38.
21. Lupu R, Mehmi I, Atlas E, Tsai MS, Pisha E, Oketch-Rabah HA, Nuntanakorn P, Kennelly EJ, Kronenberg F. (2003) Black cohosh, a menopausal remedy, does not have estrogenic activity and does not promote breast cancer cell growth. International Journal of Oncology, 23, 1407-1412.
22. Oerter Klein K, Janfaza M, Wong JA, Chang RJ. (2003) Estrogen bioactivity in fo-ti and other herbs used for their estrogen-like effects as determined by a recombinant cell bioassay. The Journal of Clinical Endocrinology and Metabolism, 88, 4077-4079.
23. Liske E, Hanggi W, Henneicke-von Zepelin HH, Boblitz N, Wustenberg P, Rahlfs VW. (2002) Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. Journal of Women's Health & Gender-Based Medicine, 11, 163-174.
24. Liu J, Burdette JE, Xu H, Gu C, Bhat KPL, van Breemen RB, Booth N, Constantinou AI, Pezzuto JM, Fong H, Farnsworth N, Bolton J. (2001) Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. Journal of Agricultural and Food Chemistry, 49, 2472-2479.
25. Kronenberg F, Fugh-Berman A. (2002) Complementary and alternative medicine (CAM) for menopausal symptoms: a review of randomized control trials. Annals of Internal Medicine, 137, 805-813. (Pubitemid 35334452)
26. Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K. (2008) Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause, 15, 51-58.
27. Burdette JE, Liu J, Chen SN, Fabricant DS, Piersen CE, Barker EL, Pezzuto JM, Mesecar A, Van Breemen RB, Farnsworth NR, Bolton JL. (2003) Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. Journal of Agricultural and Food Chemistry, 51, 5661-5670.
28. Einbond LS, Su T, Wu HA, Friedman R, Wang X, Jiang B, Hagan T, Kennelly EJ, Kronenberg F, Weinstein IB. (2007) Gene expression analysis of the mechanisms whereby black cohosh inhibits human breast cancer cell growth. Anticancer Research, 27, 697-712.
29. Jiang B, Yang H, Nuntanakorn P, Balick M, Kronenberg F, Kennelly E. (2005) The value of plant collections in ethnopharmacology: a case study of an 85-year-old black cohosh (Actaea racemosa L.) sample. Journal of Ethnopharmacology, 96, 521-528.
30. Jiang B, Kronenberg F, Nuntanakorn P, Minghua Q, Kennelly EJ. (2006) Evaluation of the botanical authenticity and phytochemical profile of black cohosh products by high-performance liquid chromatography with selected ion monitoring liquid chromatography-mass spectrometry. Journal of Agricultural and Food Chemistry, 54, 3242-3253. (Pubitemid 43798192)
31. Nuntanakorn P, Jiang B, Yang H, Cervantes-Cervantes M, Kronenberg F, Kennelly EJ. (2007) Analysis of polyphenolic compounds and radical scavenging activity of four American Actaea species. Phytochemical Analysis, 18, 219-228. (Pubitemid 46730261)
32. Einer Jensen N, Zhao J, Andersen KP, Kristoffersen K. (1996) Cimicifuga and melbrosia lack oestrogenic effects in mice and rats. Maturitas, 25, 149-153. (Pubitemid 26336680)
33. Harnischfeger G, Cillien N. (1996) Influence of Cimicifuga racemosa extract fractions on the proliferation of human carcinoma cells in vitro with regard to their estrogen receptor sensitivity. 44th Annual Congress of Georg August University, P12: 10.
34. Hou AJ, Liu YZ, Yang H, Lin ZW, Sun HD. (2000) Hydrolyzable tannins and related polyphenols from Eucalyptus globulus. Journal of Asian Natural Products Research, 2, 205-212.
35. Cote CS, Kor C, Cohen J, Auclair K. (2004) Composition and biological activity of traditional and commercial kava extracts. Biochemical and Biophysical Research Communications, 322, 147-152. (Pubitemid 39093851)
36. Warburton E, Norris PL, Goenaga-Infante H. (2007) Comparison of the capabilities of accelerated solvent extraction and sonication as extraction techniques for the quantification of kavalactones in Piper methysticum (Kava) roots by high performance liquid chromatography with ultra violet detection. Phytochemical Analysis, 18, 98-102. (Pubitemid 46487629)
37. American Botanical Council. Short Trial Finds No Effect of Black Cohosh on Menopausal Symptoms, ABC Notes Study Limitations. http://www.herbalgram.org/ default.asp?c=pockajcohosh (Accessed on 12/19/2006).
38. American Botanical Council. Research on Black Cohosh Supports Benefits in Menopause. http://www.herbalgram.org/default.asp?c=Black-Cohoh-Menopause (Accessed on 12/19/06).
39. Kretzschmar G, Nisslein T, Zierau O, Vollmer G. (2005) No estrogen-like effects of an isopropanolic extract of Rhizoma Cimicifugae racemosae on uterus and vena cava of rats after 17 day treatment. Journal of Steroid Biochemistry & Molecular Biology, 97, 271-277.
40. Viereck V, Emons G, Wuttke W. (2005) Black cohosh: just another phytoestrogen? TRENDS in Endocrinology and Metabolism, 16, 214-221.
41. Nappi RE, Malavasi B, Brundu B, Facchinetti F. (2005) Efficacy of Cimicifuga racemosa on climacteric complaints: A randomized study versus low-dose transdermal estradiol. Gynecological Endocrinology, 20, 30-35.
42. Wuttke W, Seidlova-Wuttke D, Gorkow C. (2003) The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a doubleblind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas, 44(suppl. 1), S67-67. (Pubitemid 36263037)
43. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. (2006) Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo. Annals of Internal Medicine, 145, 869-879.
44. Nisslein T, Freudenstein J. (2003) Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis. Journal of Bone and Mineral Metabolism, 21, 370-376. (Pubitemid 38017693)
45. Pockaj BA, Loprinzi CL, Sloan JA, Novotny PJ, Barton DL, Hagenmaier A, Zhang H, Lambert GH, Reeser KA, Wisbey JA. (2004) Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Investigation, 22, 515-521.
46. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. (2005) Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstetrics and Gynecology, 105, 1074-1083. (Pubitemid 40571028)
47. Reed S, Newton K, LaCroix A, Grothaus L. (2005) Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstetrics and Gynecology, 106, 1111; author reply 1111-1112.
48. Rafinesque CS, (1828) Medical Flora or Manual of the Medical Botany of the United States of North America. Atkinson & Alexander, Philadelphia, p. 88.
49. He K, Zheng BL, Kim CH, Rogers LL, Zheng QY. (2000) Direct analysis and identification of triterpene glycosides by LC/MS in black cohosh, Cimicifuga racemosa, and in several commercially available black cohosh products. Planta Medica, 66, 635-640.
50. Smith RC, Reeves JC, Dage RC, Schnettler RA. (1987) Antioxidant properties of 2-imidazolones and 2-imidazolthiones. Biochemical Pharmacology, 36, 1457-1460.
51. Lim JT, Piazza GA, Han EK, Delohery TM, Li H, Finn TS, Buttyan R, Yamamoto H, Sperl GJ, Brendel K, Gross PH, Pamukcu R, Weinstein IB. (1999) Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochemical Pharmacology, 58, 1097-1107.
52. Kulmacz RJ, Lands WEM. (1983) Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase. Prostaglandins, 25, 531-540.
53. Van Miert S, Jonckers T, Cimanga K, Maes L, Maes B, Lemiere G, Dommisse R, Vlietinck A, Pieters L. (2004) In vitro inhibition of beta-haematin formation, DNA interactions, antiplasmodial activity, and cytotoxicity of synthetic neocryptolepine derivatives. Experimental Parasitology, 108, 163-168.
54. Muhammad I, Li XC, Dunbar DC, ElSohly MA, Khan IA. (2001) Antimalarial (+)-trans-hexahydrodibenzopyran derivatives from Machaerium multiflorum. Journal of Natural Products, 64, 1322-1325.